Stockholder Equity (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Jul. 16, 2021	Jan. 31, 2022	Jan. 31, 2021	Oct. 31, 2021	Jul. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock option expense		$ 309,700	$ 0	$ 1,314,056
Additional paid-in capital		$ 384,151
Preferred stock, shares authorized		5,000,000		5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share					$ 0.001
Reverse stock split description		as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock
Reverse stock split	1-for-12
Common Stock, Shares Authorized		1,000,000,000		1,000,000,000	1,000,000,000
Common Stock, Par or Stated Value Per Share		$ 0.001		$ 0.001	$ 0.001
Common Stock, Shares, Outstanding		30,236,696		30,195,312	30,236,696
Common stock shares, issued		30,236,696		30,195,312
Issuance of warrants				4,053,750
Exercise price				$ 1.90
Warrants exercised				$ 1,665,113
Aggregate intrinsic value		$ 0		$ 0
Restricted stock unit awards description		the Company issued 61,250 shares of Common Stock to 7 employees in accordance with the vesting schedules set forth in RSU agreements previously entered into with such employees, resulting in the recognition of approximately $110,250 of share-based compensation. Of the shares issued to employees, 19,866 shares were withheld by the Company to satisfy tax withholding obligations and/or satisfy cash settlement options to employees, equaling approximately $35,759. As of January 31, 2022, there remained 437,917 unvested RSUs with approximately $900,769 of related unvested compensation.
Stock option awards, description				Company granted options exercisable for up to 150,000 shares of Common Stock of which 15,000 fully vested on March 17, 2021, 7,500 fully vested on June 30, 2021, 41,667 fully vested on December 1, 2021, 68,333 vest over the next 2 years on March 17, 2022, and 2023, and 17,500 vest over the next 2 years on June 30, 2022 and 2023. The options have exercise prices ranging from $9.12 to $28.68 per share. These options have a weighted average remaining life of 9.43 years as of October 31, 2021 and of 9.08 years as of January 31, 2022. The options expire in the year 2031. On July 19, 2021, two of the stock option agreements, exercisable for an aggregate of 50,000 shares of Common Stock, were modified to accelerate the full vesting period from 3 years to 2 years. The Company granted no new options during the three months ended January 31, 2022. The aggregate intrinsic value of these outstanding options as of October 31, 2021 and January 31, 2022 was $0.
Fair valued of options granted		$ 3,088,002
Stock price		$ 9.12
Expected term		10 years
Unamortized stock option expense		$ 1,004,356
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock price		$ 27.36
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		301.53%	301.53%
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRates]		1.63%
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		294.57%	294.57%
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRates]		1.19%
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of warrants				879,828
Common Stock Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Weighted average remaining term		4 years 8 months 4 days
Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Additional paid-in capital		$ 74,451
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					3,000,000
Preferred Stock, Shares Outstanding					3,000,000
Preferred stock, shares issued		3,000,000